Livongo Health (LVGO) Announces Preliminary Q1 Revenue

Go back to Livongo Health (LVGO) Announces Preliminary Q1 Revenue

Needham & Company Sees Additional Positive Revisions for Livongo Health Inc. (LVGO)

April 7, 2020 11:55 AM EDT

Needham & Company analyst Scott Berg reiterated a Buy rating and $42.00 price target on Livongo Health Inc. (NASDAQ: LVGO), saying today's positive pre-announcement suggests additional positive revisions are on the horizon.

Before the open, Livongo said it now expects revenue for the... More